Castle Biosciences Inc.
Organization details
- Legal name
- Castle Biosciences Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8071 — Services-Medical Laboratories
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Friendswood
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CSTL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001447362
- EIN
- 77-0701774
Board of directors
-
Daniel Bradbury · DirectorSince 2023
-
Derek J. Maetzold · Director · Pres. & Chief Exec. OfficerSince 2023
-
Ellen Goldberg · DirectorSince 2023
-
G. Bradley Cole · DirectorSince 2023
-
Kim Caple · DirectorSince 2023
-
Mara G. Aspinall · DirectorSince 2023
-
Miles Harrison · DirectorSince 2023
-
Rodney Cotton · DirectorSince 2024
-
Tiffany Olson · DirectorSince 2023
Director election results
Annual meeting of May 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
63.7%
-
68.5%
-
69.1%
Board connections
4 of this board's directors also sit on 5 other boards. 5 are in the same sector.
-
Equillium Inc. Same sectorvia Daniel Bradbury
-
Kiniksa Pharmaceuticals International plc Same sectorvia G. Bradley Cole
-
MiMedx Group Inc Same sectorvia Tiffany Olson
-
OraSure Technologies Inc. Same sectorvia Mara G. Aspinall
-
Vivani Medical Inc. Same sectorvia Daniel Bradbury
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $18,710,043
- 217 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Derek J. Maetzold Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | −7,555 | $36.01 | $272,018 |
| Nov 2, 2026 | Derek J. Maetzold Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | −2,816 | $36.01 | $101,390 |
| Nov 2, 2026 | Derek J. Maetzold Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | −2,393 | $36.01 | $86,160 |
| Nov 2, 2026 | Derek J. Maetzold Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | −1,025 | $36.81 | $37,734 |
| Nov 2, 2026 | Derek J. Maetzold Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | −382 | $36.81 | $14,063 |
| Nov 2, 2026 | Derek J. Maetzold Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | −325 | $36.81 | $11,965 |
| Oct 28, 2026 | Juvenal Tobin W Officer (Chief Commercial Officer) | Open-market sale | −1,237 | $35.58 | $44,009 |
| Oct 28, 2026 | Juvenal Tobin W Officer (Chief Commercial Officer) | Open-market sale | −5,341 | $36.62 | $195,582 |
| Oct 26, 2026 | Juvenal Tobin W Officer (Chief Commercial Officer) | Open-market sale | −3,288 | $33.08 | $108,767 |
| Oct 19, 2026 | Derek J. Maetzold Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | −8,580 | $31.91 | $273,788 |
| Oct 19, 2026 | Derek J. Maetzold Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | −3,198 | $31.91 | $102,048 |
| Oct 19, 2026 | Derek J. Maetzold Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | −2,718 | $31.91 | $86,731 |
| Oct 5, 2026 | Derek J. Maetzold Director, Officer (Pres. & Chief Exec. Officer) | Option exercise | +8,165 | $2.39 | $19,514 |
| Oct 5, 2026 | Derek J. Maetzold Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | −8,580 | $35.57 | $305,156 |
| Oct 5, 2026 | Derek J. Maetzold Director, Officer (Pres. & Chief Exec. Officer) | Open-market sale | −3,198 | $35.57 | $113,740 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Castle Biosciences Inc.
How many directors are on Castle Biosciences Inc.'s board?
Castle Biosciences Inc.'s board has 9 directors: Daniel Bradbury, Derek J. Maetzold, Ellen Goldberg, G. Bradley Cole, Kim Caple, Mara G. Aspinall, Miles Harrison, Rodney Cotton and Tiffany Olson.
Are Castle Biosciences Inc. insiders buying or selling shares?
Over the last 12 months, Castle Biosciences Inc. insiders made no open-market purchases and sold $18.7 million of shares in 217 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="castle-biosciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.